Ashton Tweed Connection Vol. 3 No. 1

Featuring CEO Interview with Kathleen P. DeLawrence, COO, Ability Prosthetics & Orthotics, Inc.

Volume 3, Number 1

Whether you are or you require executive or management talent — interim, permanent, or interim to hire — Ashton Tweed can meet your specialized retained search and executive search needs.

CEO Leadership Series: Kathleen P. DeLawrence, COO, Ability Prosthetics & Orthotics, Inc.

CEO Leadership Series: Kathleen P. DeLawrence, Chief Operating Officer, Ability Prosthetics & Orthotics, Inc.

Highly experienced Chief Operating Officer, Kathleen DeLawrence, discusses the power of making connections, seizing new opportunities, and her journey through the pharmaceutical, life sciences, and healthcare industries.

Chief Medical Officer Aids Biotech Funding in Interim

A small biotech located in New Jersey needed the expertise of an interim Chief Medical Officer to help their company while they raised additional funding for their product. However, the company required that the interim professional have cancer immunotherapy experience and an MD…

5 Guidelines For Working With An Interim Executive

Hiring an interim executive in times of need can be a reliable strategy for your company’s success. Although preparing and interacting with an interim leader is very similar to how you would handle a permanent employee, there are some key differences. Having negotiated interim hires…


	DON’T MISS THE NEW LIFE SCIENCES WEEKLY DIGEST! Go beyond our newsletter… Subscribe Today for Ashton Tweed’s Weekly Digest Emails that cover hiring, firing, and retiring news in the Life sciences. Click below to enhance your subscription:

Top health industry issues of 2016 from PwC

In 2016, there will be a lot of firsts in the health industry. PwC’s Health Research Institute’s annual Top health industry issues report pinpoints what is expected to have the most impact on the industry in 2016 in addition to highlighting key trends from the past decade…

Highlights from the J.P. Morgan Healthcare Conference 2016

Life science executives and investors descended upon San Francisco to share news and deal opportunities at the 34^th annual J.P. Morgan Healthcare Conference, held January 11-14. Here, DDDmag has rounded up some of the top news that came out of the conference.

11 execs & experts predict what’s in store for biopharma in 2016

Big changes are happening in biopharma and many of 2015’s trends will continue to unfold. BioPharma Dive gathered predictions from top thought leaders in the industry on what comes next in pricing, M&As, drug development, transparency, and much more…

What’s Ahead for Medical Device Cybersecurity in 2016?

Josh Corman, cofounder of I Am The Cavalry, and one of the organizers of the CyberMedRx Medical CyberSafety Summit held in December, discusses the push to increase medtech cybersecurity and what he believes will be key achievements this year.

BioNJ’s 23rd Annual Gateway Gala

BioNJ’s 23rd Annual Dinner Meeting & Innovation Celebration, taking place on February 4, 2016 at the Hilton East Brunswick, will bring together 800 life sciences professionals for a night of networking and fun! The inspirational evening will include a Keynote by…

Vaccines present ‘biggest breakthrough’ in animal health

In a recent report titled “Innovation in animal health,” HealthforAnimals called vaccination the “biggest breakthrough” in the field in the past 100 years, with the global market for animal health vaccines expected to hit $7.2B by 2020.

Money-back guarantees on cancer drugs are real in Italy

Italy and its money-back guarantees on cancer drugs are sparking interest in the US and Europe. With more drugs fast-tracked through regulatory review, Italy uses these deals to stay on the cutting edge of treatment...